Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0000950170-24-059506

Chief Executive Officer sold 5,000 shares at $13.22 ($66,093)

  • Chief Executive Officer acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Townsend Richard Nolan · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-13 Exercise or conversion : show line 1 in the form 10b5-1 +5,000 $2.33 $11,650 175,695 D
2024-05-13 Sale : show line 2 in the form 10b5-1 −5,000 $13.22 $66,093 170,695 D
Open-market sales · 5,000 sh · avg $13.22 · $66,093

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-13 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −5,000 $2.33 $11,650 148,655 D
Loading xslF345X05/ownership.xml…